We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.4B
$69.4B $21.71 0.56%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49.1B
$49.1B $42.06 1.2%
HLN icon
3
Haleon
HLN
$40.1B
$40.1B $9.13 0.76%
ZTS icon
4
Zoetis
ZTS
$34B
$34B $83.80 0.7%
UTHR icon
5
United Therapeutics
UTHR
$24.6B
$24.6B $578.09 1.67%
VTRS icon
6
Viatris
VTRS
$23.6B
$23.6B $20.61 0.63%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.7B
$16.7B $165.41 0.06%
ELAN icon
8
Elanco Animal Health
ELAN
$13B
$13B $26 1.55%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.4B
$12.4B $14.87 1.16%
ALKS icon
10
Alkermes
ALKS
$7.6B
$7.6B $45.24 2.77%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.41B
$7.41B $94.28 0.05%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.34B
$7.34B $21.08 0.71%
LNTH icon
13
Lantheus
LNTH
$6.66B
$6.66B $101.83 0.11%
SUPN icon
14
Supernus
SUPN
$6.08B
$6.08B $29.28 1.56%
LQDA icon
15
Liquidia
LQDA
$5.04B
$5.04B $55.88 0.87%
HIMS icon
16
Hims & Hers Health
HIMS
$4.09B
$4.09B $17.45 5.98%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.48B
$3.48B $27.10 2.52%
BHC icon
18
Bausch Health
BHC
$3.11B
$3.11B $8.31 1.31%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.07B
$3.07B $16.78 0.48%
HCM icon
20
HUTCHMED
HCM
$2.5B
$2.5B $14.38 2.38%
PBH icon
21
Prestige Consumer Healthcare
PBH
$2.29B
$2.29B $48.41 0.85%
PRGO icon
22
Perrigo
PRGO
$2.23B
$2.23B $16.10 0.49%
RGC icon
23
Regencell Bioscience
RGC
$2.2B
$2.2B $4.44 5.93%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.92B
$1.92B $7.46 0.13%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.85B
$1.85B $64.28 0.63%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $369B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.4B, Teva Pharmaceutical Industries (TEVA) at $49.1B and Haleon (HLN) at $40.1B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.